Status:
UNKNOWN
Electrocardiogram Analysis in COVID-19 Patients
Lead Sponsor:
University Hospital of Ferrara
Conditions:
SARS-CoV Infection
Eligibility:
All Genders
18-100 years
Brief Summary
Electrocardiographic (ECG) evaluation of patients with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection. The present study involves three different phases of evaluation of the E...
Detailed Description
In the early months of 2020, SARS-CoV-2 virus infection quickly spread around the world to a pandemic. On 2 April 2020, confirmed cases of coronavirus disease 2019 (COVID-19) worldwide exceeded one mi...
Eligibility Criteria
Inclusion
- age \>18 years old
- confirmed SARS-CoV-2 infection (pharyngeal swab positive for viral RNA or clinical diagnosis of COVID-19 based on chest x-ray or high resolution CT)
- hospitalization in a hospital setting
Exclusion
- SARS-CoV-2 infection not confirmed by pharyngeal swab or clinical-radiographic criteria
- absence of ECG tracing performed at the time of hospitalization
Key Trial Info
Start Date :
April 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
1014 Patients enrolled
Trial Details
Trial ID
NCT04367129
Start Date
April 14 2020
End Date
April 1 2021
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arcispedale S. Anna
Ferrara, Italy, 44124